![David Kirn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kirn
Founder at
4D MOLECULAR THERAPEUTICS, INC.
Net worth: 15 M $ as of 31/05/2026
Profile
David H.
Kirn was the founder of SillaJen Biotherapeutics, Inc., founded in 2006, where the title held was President & Chief Medical Officer in 2012.
Dr. Kirn is the founder of 4D Molecular Therapeutics, Inc., founded in 2013, holding the titles of President, Chief Executive Officer & Director starting in 2026.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc...
Dr. Kirn is Chief Executive Officer at ReIGNITE Therapeutics, Inc. Dr. Kirn is Director at Coagulant Therapeutics, Inc. Dr. Kirn is Professor at the University of Oxford.
Former positions include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc. in 2009, Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Education includes an undergraduate degree from the University of California, Berkeley in 1985 and a doctorate from The University of California, San Francisco in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/06/2026 | 1,542,485 ( 2.95% ) | 15 M $ | 31/05/2026 |
David Kirn active positions
| Companies | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Founder | 12/09/2013 |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Coagulant Therapeutics, Inc.
 Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Director/Board Member | - |
Former positions of David Kirn
| Companies | Position | End |
|---|---|---|
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Founder | 01/01/2019 |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Corporate Officer/Principal | - |
Specialist Diabetes Research & Treatment Centre LLC
 Specialist Diabetes Research & Treatment Centre LLC Medical/Nursing ServicesHealth Services Operates diabetes treatment centers | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of David Kirn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
Specialist Diabetes Research & Treatment Centre LLC
Specialist Diabetes Research & Treatment Centre LLC Medical/Nursing ServicesHealth Services Operates diabetes treatment centers | Health Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Health Technology |
Coagulant Therapeutics, Inc.
Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Health Technology |
- Stock Market
- Insiders
- David Kirn
